Prevalence of gestational diabetes mellitus based on glucose tolerance test on weeks 24 to 28. Prospective cohort in Armenia, Colombia, 2015-2016
DOI:
https://doi.org/10.18597/rcog.3056Keywords:
Glycosilated haemoglobin A, gestational diabetes mellitusAbstract
Objective: To determine the prevalence of gestational diabetes mellitus that appears during the second or the third trimester of pregnancy using a glucose tolerance test, and to explore the relationship with pregnancy outcomes in pregnant women in Armenia.
Materials and methods: Prospective cohort study in pregnant women coming to a Level I clinic in Armenia for prenatal care before 14 weeks of gestation who signed the informed consent. Pregnant women with hypertension or existing diabetes before pregnancy or with conditions that could alter HbA1c were excluded. Consecutive sampling: Blood sugar and HbA1c were measured on admission and the glucose tolerance test with 75 g was measured at 24-28 weeks; perinatal and maternal outcomes were measured at the time of delivery. A descriptive analysis is performed and the prevalence of gestational diabetes mellitus is presented.
Results: Of a total of 372 candidates to enter the study, there were two cases (0.5%) of pre-gestational diabetes mellitus. Of the 370 pregnant women who met the selection criteria, 43 (11.6%) had a miscarriage, and 36 (9.7%) were lost to follow-up before 24 weeks; of the remaining 291 women, 35 (12%) did not undergo the glucose tolerance test. The glucose tolerance test was performed in 256 pregnant women and it was abnormal in 12 cases, for a prevalence of gestational diabetes mellitus of 4.7% (12/256).
Conclusions: The prevalence of gestational diabetes mellitus was 4.7% in the study population, although frequency may have been underestimated due to losses before 24 weeks. No adverse perinatal outcomes were found in this group of pregnant women.Author Biographies
Bayron Manuel Ruiz-Hoyos
Médico ginecoobstetra; magíster en Educación. Profesor Asociado, Universidad del Quindío, Armenia (Colombia). bruiz58@yahoo.com.mx
Ángela Liliana Londoño-Franco
Médica epidemióloga; doctora en Medicina Preventiva y Salud Pública. Profesor Asociado, Universidad del Quindío, Armenia (Colombia). angelalilianal@uniquindio.edu.co
Rosa Amparo Ramírez-Aristizábal
References
Vidaeff A, Yeomans E, Ramón S. Gestational diabetes: A field of controversy. Obst Gynecol Surv. 2003;58:759-69. https://doi.org/10.1097/01.OGX.0000093782.25261.AC
Cortés H, Ocampo I, Villegas A. Prevalencia de diabetes mellitus gestacional en una población de Medellín de 1999-2000. Valor predictivo positivo de la prueba tamiz y comparación con los criterios de la NDDG y la ADA. Rev Colomb Obstet Ginecol. 2002;53:81-5.
Burbano-López R, Castaño-Castrillón J, González-Castellanos L, González-Henao H, Quintero-Ospina J, Revelo-Imbacuan L, et al. Frecuencia de diabetes mellitus gestacional y factores de riesgo en gestantes atendidas en clínicas de Assbasalud ESE, Manizales (Colombia), 2011-2012: estudio de corte transversal. Rev Colomb Obstet Ginecol. 2014;65:338-45. https://doi.org/10.18597/rcog.38
Mayo K, Melamed N, Vandenberghe H, Berger H. The impact of adoption of the International Association of Diabetes in Pregnancy Study Group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol. 2015;212:224.e1-e9.
Ethridge J, Catalano P, Waters T. Perinatal outcomes associated with the diagnosis of gestational diabetes made by the international association of the diabetes and pregnancy study groups criteria. Obstet Gynecol. 2014;124:571-8.
National Institute for Health and Care Excellence. Diabetes in pregnancy: Management of diabetes and its complications from preconception to the postnatal period. NICE guideline Published: 25 February 2015. nice.org.uk/guidance/ng3.
World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO/NMH/MND/13.2 2013.
American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 2015;38:S8-S16.
Buchanan T, Xiang A. Gestational diabetes mellitus. J Clin Invest. 2005;115:485-91.
Campo-Campo M, Posada-Estrada G. Factores de riesgo para diabetes gestacional en población obstétrica en tres instituciones de Medellín, Colombia. Estudio de casos y controles. Rev Colomb Obstet Ginecol. 2012;63:114-8.
Ortiz CE, Carrillo M. La embarazada diabética. Aspectos fisiopatológicos. Revista Controversias en Ginecología y Obstetricia. 2003;11:1380-8.
Murphy H. Gestational Diabetes: what's new? Medicine. 2010;38:676-8.
McCance D. Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab. 2011;25:945-58.
Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: The impact of glycemic control. Am J Obstet Gynecol. 2004;191:1655-60. https://doi.org/10.1016/j.ajog.2004.03.074
Whitelaw B, Gayle C. Gestational diabetes. Obstet Gynaecol Reprod Med. 2010;21:41-6. https://doi.org/10.1016/j.ogrm.2010.11.001
Chauhan S, Grobman W, Gherman R, Chauhan V, Chang G, Magann E, et al. Suspicion and treatment of the macrosomic fetus: A review. Am J Obstet Gynecol. 2005;193:332-46. https://doi.org/10.1016/j.ajog.2004.12.020
Bernstein I. Fetal body composition. Review. Curr Opin Clin Nutr Metab Care. 2005;8:613-7.
Ministerio de Salud y Protección Social. Guía de Práctica Clínica (GPC) para la prevención, detección temprana y tratamiento de las complicaciones, del parto o puerperio. 2013. http://gpc.minsalud.gov.co/GPC_SITES/REPOSITORIO/CONV_500/GPC_EMBARAZO/GPC_EMBARAZO_COMPLETA.ASPX
Ministerio de Salud y Protección Social. Guía de Práctica Clínica (GPC) para el diagnóstico, tratamiento y seguimiento de la Diabetes Gestacional 2016. http://gpc.minsalud.gov.co/gpc_sites/repositorio/conv_637/gpc_diabetes/gpc_diabetes_gestacional_completa.aspx
International Association of Diabetes and Pregnancy Study Groups Recommendations on the diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care. 2010;33:676-82. https://doi.org/10.2337/dc09-1848.
American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2005;28:S4-S36.
World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO Consultation. Diabetes Research and Clinical Practice. 2011;93:299-309. https://doi.org/10.1016/j.diabres.2011.03.012
American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2011;34:S1-S61.
Blumer I, Hadar E, Hadden D, Jovanovic L, Mestman J, Murad M, et al. Diabetes and pregnancy: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab. 2013;98:4227-49.
Márquez J, Monterrosa A, Romero I, Arteta C. Diabetes gestacional: estado actual en el tamizaje y diagnóstico. Rev Cienc Biomed. 2011;2:297-304.
Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care. 2009; 32:1639-43. https://doi.org/10.2337/dc09-0688
Amylidi S, Mosimann B, Stettler C, Fiedler G, Surbek D, Raio L. First-trimester glycosylated hemoglobin in women at high risk for gestational diabetes. Acta Obstet Gynecol Scand. 2016;95:93-7. https://doi.org/10.1111/aogs.12784
Peacock I. Glycosylated haemoglobin: Measurement and clinical use. Review Article. J Clin Pathol. 1984;37:841-51.
Gillet M. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-34. https://doi.org/10.2337/dc09-9033
Drzewoski J, Drozdowska A. Could glycated hemoglobin be used as a diagnostic tool in diabetes mellitus? Pol Arch Med Wewn. 2010;120:109-13.
Homa K, Majkowska L. Difficulties in interpreting HbA1c results. Pol Arch Med Wewn. 2010;120:148-54.
Herman W, Fajans S. Hemoglobin A1c for diagnosis of diabetes. Practical considerations. Pol Arch Med Wewn. 2010;120:37-41.
Ruiz-Hoyos B, Giraldo-Garcia A, Landazuri P. Niveles de leptina en la primera y segunda mitad del embarazo en gestantes de Armenia, Colombia, 2011. Estudio de cohorte. Rev Colomb Obstet Ginecol. 2014;65:41-6. https://doi.org/10.18597/rcog.78
Riskin-Mashiah S, Damti A, Younes G, Auslander R. Normal fasting plasma glucose levels during pregnancy: A hospital-based study. J Perinat Med. 2011;39:209-11.
Leary J, Pettitt D, Jovanovi L. Gestational diabetes guidelines in a HAPO world. Best Practice & Research. Clinical Endocrinology & Metabolism. 2010;24;673-85.
The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
Kwon S, Kwon J, Park Y, Kim Y, Lim J. HbA1c for diagnosis and prognosis of gestational diabetes mellitus. Diabetes Res Clin Pract. 2015;110:38-43. https://doi.org/10.1016/j.diabres.2015.07.014
Khalafallah A, Phuah E, Al-Barazan A, Nikakis I, Redford A, Clarkson W. et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open 2016;6:e011059.
Berggren E, Boggess K, Stuebe A, Funk M. National Diabetes Data Group vs Carpenter-Coustan criteria to diagnose gestational diabetes. Am J Obstet Gynecol. 2011:253.e1-7.
Brown F, Wyckoff J. Application of One-Step IADPSG versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on health services, clinical care, and outcomes. Curr Diab Rep. 2017;17:85. https://doi.org/10.1007/s11892-017-0922-z
Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer A, Metzger, BE et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel–recommended criteria: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012;35:526-8. doi: 10.2337/dc11-1641. https://doi.org/10.2337/dc11-1641.
Durán A, Sáenz S, Torrejón M, Bordiú E, del Valle L, Galindo M, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: The St. Carlos Gestational Diabetes Study. Diabetes Care. 2014;37:2442-50. https://doi.org/10.2337/dc14-0179
Hirst JE, Tran TS, Do MA, Morris JM, Jeffery HE. Consequences of gestational diabetes in an urban hospital in Viet Nam: A prospective cohort study. PLoS Med. 2012;9(7):e1001272. doi: 10.1371/journal.pmed.1001272. https://doi.org/10.1371/journal.pmed.1001272
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477-86. https://doi.org/10.1056/NEJMoa042973.
Pérez D, Panta A. Factores epidemiológicos asociados al aborto. Ginecol Obstet. 1995;41:48-51.
Regan L, Backos M, Rai R. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriages. Royal College of Obstetricians and Gynaecologists Green-top guideline, 17. London: RCOG Press; 2011.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Revista Colombiana de Obstetricia y Ginecología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
